Search Results

Gritgen Therapeutics Co., Ltd., a biotechnology company focused on discovering and developing innovative gene therapy products, announces the successful validation and official launching of operations at its commercial GMP facility located in Suzhou Industrial Park.

Nortech Systems Incorporated is proud to announce that its Suzhou, China facility has been certified by the National Medical Products Administration to produce Class II Medical Devices for customers in Asia.

Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.

Suzhou OSAI Biopharma, Inc., a biopharmaceutical company focused on developing live biotherapeutic products (LBPs), today announced that its Phase III clinical trial of vaginal L. crispatus live bacteria capsule (Lc262-1) has successfully met its primary and secondary endpoints.

111, Inc. (“111" or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced a strategic cooperation agreement with Suzhou Zelgen Biopharmaceuticals Co., Ltd. (“Zelgen”) (688266.SH), an innovative drug R&D and production company.

Suzhou Zelgen Biosciences completed a $62M series B financing to support its portfolio of small molecule and biologic drug candidates.

NeoMab Biotechnology Co., Ltd. celebrated its grand opening in Suzhou Industrial Park.